Dianthus Therapeutics Chief Accounting Officer Edward Carr disposes of shares for $2.01 million

Dianthus Therapeutics reported Chief Accounting Officer Edward Carr exercised stock options for 20,000 shares at USD 17.88 on Sep. 17, 2026. Carr sold 20,000 shares the same day at weighted-average prices from USD 100.43 to USD 104.39. His directly held common stock position fell to zero following the transactions. He reported beneficial ownership of 43,818 stock options after the exercise. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001273351-26-000006), on September 18, 2026, and is solely responsible for the information contained therein. (C)